Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion

por van Zuylen, Vanessa-Leigh, den Haan, Melina C, Roelofs, Helene, Fibbe, Willem E, Schalij, Martin J, Atsma, Douwe E
Publicado 2015

Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors

por Levens, Amar D., den Haan, Melina C., Jukema, J. Wouter, Heringa, Mette, van den Hout, Wilbert B., Moes, Dirk Jan A. R., Swen, Jesse J.
Publicado 2023

Discrepant Results of Experimental Human Mesenchymal Stromal Cell Therapy after Myocardial Infarction: Are Animal Models Robust Enough?

por den Haan, Melina C., van Zuylen, Vanessa-Leigh, Pluijmert, Niek J., Schutte, Cindy I., Fibbe, Willem E., Schalij, Martin J., Roelofs, Helene, Atsma, Douwe E.
Publicado 2016

Hypercholesterolemia affects cardiac function, infarct size and inflammation in APOE*3-Leiden mice following myocardial ischemia-reperfusion injury

por Pluijmert, Niek J., den Haan, Melina C., van Zuylen, Vanessa L., Steendijk, Paul, de Boer, Hetty C., van Zonneveld, Anton J., Fibbe, Willem E., Schalij, Martin J., Quax, Paul H. A., Atsma, Douwe E.
Publicado 2019

Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts

por den Haan, Melina C, Grauss, Robert W, Smits, Anke M, Winter, Elizabeth M, van Tuyn, John, Pijnappels, Daniël A, Steendijk, Paul, Gittenberger-De Groot, Adriana C, van der Laarse, Arnoud, Fibbe, Willem E, de Vries, Antoine A F, Schalij, Martin J, Doevendans, Pieter A, Goumans, Marie-José, Atsma, Douwe E
Publicado 2012